Biobank Status (Manual Updates)

The code block below illustrates how one might use # and // as comments in your logic and calculations.

This value you provided is not a number. Please try again.

This value you provided is not an integer. Please try again.

The value entered is not a valid Vanderbilt Medical Record Number (i.e. 4- to 9-digit number, excluding leading zeros). Please try again.

The value you provided must be within the suggested range

The value you provided is outside the suggested range

This value is admissible, but you may wish to double check it.

The value entered must be a time value in the following format HH:MM within the range 00:00-23:59 (e.g., 04:32 or 23:19).

This field must be a 5 or 9 digit U.S. ZIP Code (like 94043). Please re-enter it now.

This field must be a 10 digit North American phone number (like 415 555 1212). Please re-enter it now.

This field must be a valid email address (like joe@user.com). Please re-enter it now.

The value you provided could not be validated because it does not follow the expected format. Please try again.

Required format:

n2ggFzoGqfztD8zmLzjQrR625NvBFWrCpE5CfRENitAJyizjh3FJGhe4iu6MYtuUJtqukIxWXU5kzszmzBbVurvUzJavxW8HIcPYUqU37

Displaying recently generated information

Biobank Status (Manual Updates)

The Ottawa GynePath Biobank

Open to recruitment!

Total Number of Consented Participants: 23

Primary indication for surgery of consented participants:

Endometriosis:	21
Uterine Fibroids:	0
Adenomyosis:	0
Ovarian Cancer:	0
Other:	1

Current Research Studies using Ottawa GynePath Biobank samples and data:

Ethnic and racial disparity in endometriosis pathobiology and treatment.

Principal Investigator: Sukhbir Singh

Funding Agency: Canadian Institutes of Health Research - Funding Announcement

Abstract: Endometriosis tissue and blood is collected from patients receiving surgical intervention. Specimens will be used to identify genetic/histologic/cellular variations among different race/ethnicity groups. Machine learning techniques will be used to develop predictive models for early diagnosis and therapeutic targets. Cell lines and models of endometriosis will be developed to investigate cellular and molecular basis of disease.

Start Date: June 2026

End Date: March 2030

Contact Information
Email: OttawaGynepathBiobank@ohri.ca
Phone: 613-738-8400 x81743
omig.ca

OHSN-REB ID: 20250735-01H